Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations
SEC Form 4
Patrick John Finn, COO of Twist Bioscience, sold 2,885 shares of common stock on August 5, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On August 5, 2024, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 2,885 shares of common stock.
- The sale was executed at a price of $39.926 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Finn directly owns 168,327 shares of Twist Bioscience Corp.
- The sale was mandated by Twist Bioscience's equity incentive plan, requiring a 'sell to cover' transaction to satisfy tax obligations.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (sell to cover taxes) by an executive, which is neither particularly positive nor negative. It's a neutral event in the context of investment analysis.
Industry Context
Sales to cover taxes on vesting equity are a common practice among company executives and do not necessarily reflect a negative outlook on the company's future.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a small percentage of the total outstanding shares and is for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Date of stock sale transaction |
| 08/07/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.